光滑念珠菌感染与中性粒细胞减少的骨髓移植患者氟康唑预防用药的相关性。
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
作者信息
Wingard J R, Merz W G, Rinaldi M G, Miller C B, Karp J E, Saral R
机构信息
Johns Hopkins Oncology Center, Baltimore, Maryland 21205.
出版信息
Antimicrob Agents Chemother. 1993 Sep;37(9):1847-9. doi: 10.1128/AAC.37.9.1847.
Abstract
Because the use of fluconazole prophylaxis had been associated with an increased rate of Candida krusei infections at The John Hopkins Oncology Center, early empiric amphotericin B plus flucytosine were given to febrile neutropenic patients colonized by C. krusei. By this practice, the proportion of fungemias attributable to C. krusei was low (12.5%) in patients receiving fluconazole over a 6-month interval. However, Torulopsis (Candida) glabrata assumed a much higher proportion of fungemias (75%) among patients receiving fluconazole. In vitro susceptibility testing combined with this clinical experience suggests that some T. glabrata isolates are not susceptible to fluconazole and can cause breakthrough infections in patients receiving fluconazole.
摘要
由于在约翰霍普金斯肿瘤中心，氟康唑预防用药与克鲁斯念珠菌感染率增加有关，因此对于定植有克鲁斯念珠菌的发热性中性粒细胞减少患者，早期给予经验性两性霉素B加氟胞嘧啶治疗。通过这种做法，在6个月期间接受氟康唑治疗的患者中，由克鲁斯念珠菌引起的真菌血症比例较低（12.5%）。然而，在接受氟康唑治疗的患者中，光滑念珠菌（念珠菌属）在真菌血症中所占比例要高得多（75%）。体外药敏试验结合这一临床经验表明，一些光滑念珠菌分离株对氟康唑不敏感，可在接受氟康唑治疗的患者中引起突破性感染。
相似文献
1
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.光滑念珠菌感染与中性粒细胞减少的骨髓移植患者氟康唑预防用药的相关性。
Antimicrob Agents Chemother. 1993 Sep;37(9):1847-9. doi: 10.1128/AAC.37.9.1847.
2
Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.高危异基因骨髓移植后光滑念珠菌和克柔念珠菌血症：低剂量氟康唑预防对发病率和结局无不良影响
Bone Marrow Transplant. 2001 Nov;28(9):873-8. doi: 10.1038/sj.bmt.1703252.
3
Fluconazole resistance of Candida krusei.克鲁斯念珠菌对氟康唑的耐药性。
Boll Ist Sieroter Milan. 1991;70(1-2):527-9.
4
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
5
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.接受氟康唑预防性治疗的骨髓移植和中性粒细胞减少患者中克鲁斯念珠菌感染增加。
N Engl J Med. 1991 Oct 31;325(18):1274-7. doi: 10.1056/NEJM199110313251803.
6
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.氟康唑预防在化疗引起的中性粒细胞减少症患者中的应用。
Leuk Lymphoma. 1992 Nov;8(4-5):353-9. doi: 10.3109/10428199209051014.
7
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.癌症免疫功能低下患者中光滑念珠菌和白色念珠菌血症的流行病学
Am J Med. 2002 Apr 1;112(5):380-5. doi: 10.1016/s0002-9343(01)01130-5.
8
The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team.氟康唑预防对中性粒细胞减少癌症患者真菌定植的影响。骨髓移植团队。
J Antimicrob Chemother. 1994 Feb;33(2):309-18. doi: 10.1093/jac/33.2.309.
9
Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.氟康唑预防与恶性肿瘤中性粒细胞减少儿童的念珠菌血症
Haematologica. 1993 Jul-Aug;78(4):249-51.
10
Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei.氟康唑与两性霉素B对热带念珠菌、光滑念珠菌和克柔念珠菌的体内活性比较。
Antimicrob Agents Chemother. 1989 Sep;33(9):1443-6. doi: 10.1128/AAC.33.9.1443.
引用本文的文献
1
Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens.毕赤酵母（克鲁维酵母）：一项旨在为世界卫生组织真菌病原体优先次序清单提供信息的系统综述。
Med Mycol. 2024 Jun 27;62(6). doi: 10.1093/mmy/myad132.
2
Candida auris-a systematic review to inform the world health organization fungal priority pathogens list.Candida auris- 一项旨在为世界卫生组织真菌优先病原体清单提供信息的系统评价。
Med Mycol. 2024 Jun 27;62(6). doi: 10.1093/mmy/myae042.
3
ICU-acquired infections in immunocompromised patients.免疫功能低下患者 ICU 获得性感染。
Intensive Care Med. 2024 Mar;50(3):332-349. doi: 10.1007/s00134-023-07295-2. Epub 2024 Jan 10.
4
Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009-2020.突破恶性血液病伴发的念珠菌血症：来自日本 2009 年至 2020 年单中心回顾性研究的结果。
Med Mycol. 2023 Jun 5;61(6). doi: 10.1093/mmy/myad056.
5
Infections in Hospitalized Cancer Patients.住院癌症患者的感染
World J Oncol. 2021 Dec;12(6):195-205. doi: 10.14740/wjon1410. Epub 2021 Dec 8.
6
A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients.多中心、随机、开放标签研究：比较米卡芬净与氟康唑在预防活体肝移植受者侵袭性真菌感染中的作用。
J Gastrointest Surg. 2020 Apr;24(4):832-840. doi: 10.1007/s11605-019-04241-w. Epub 2019 May 7.
7
Advances in Candida detection platforms for clinical and point-of-care applications.用于临床和即时护理应用的念珠菌检测平台的进展。
Crit Rev Biotechnol. 2017 Jun;37(4):441-458. doi: 10.3109/07388551.2016.1167667. Epub 2016 Apr 19.
8
Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy.在一名接受长期抗真菌治疗的持续性念珠菌血症患者的一系列近平滑念珠菌分离株中氟康唑耐药性的发展。
BMC Infect Dis. 2015 Aug 18;15:340. doi: 10.1186/s12879-015-1086-6.
9
Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.氟康唑预防用药与住院腹部手术患者真菌微生物学的关系：一项描述性队列研究。
Crit Care. 2014 Oct 29;18(5):590. doi: 10.1186/s13054-014-0590-1.
10
Systemic antifungal drugs: Are we making any progress?全身性抗真菌药物：我们有取得任何进展吗？
Can J Infect Dis. 1994 Mar;5(2):59-61. doi: 10.1155/1994/828061.
本文引用的文献
1
Incidence of polyene-resistant yeasts recovered from clinical specimens.从临床标本中分离出的多烯耐药酵母的发生率。
Antimicrob Agents Chemother. 1980 Jul;18(1):158-63. doi: 10.1128/AAC.18.1.158.
2
Fluconazole resistance in Candida glabrata.光滑念珠菌对氟康唑的耐药性。
Lancet. 1988 Dec 3;2(8623):1310. doi: 10.1016/s0140-6736(88)92919-4.
3
Fluconazole and Candida krusei fungemia.
N Engl J Med. 1991 Oct 31;325(18):1315.
4
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.接受氟康唑预防性治疗的骨髓移植和中性粒细胞减少患者中克鲁斯念珠菌感染增加。
N Engl J Med. 1991 Oct 31;325(18):1274-7. doi: 10.1056/NEJM199110313251803.
5
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.一项关于氟康唑预防骨髓移植患者真菌感染的对照试验。
N Engl J Med. 1992 Mar 26;326(13):845-51. doi: 10.1056/NEJM199203263261301.
Zotero 插件